跳至主要内容
临床试验/CTRI/2021/07/034943
CTRI/2021/07/034943已完成2/3 期

Comparison of efficacy of single-dose Oral Mifepristone with Transcervical Foley catheter for pre-induction cervical ripening in singleton term and late-term pregnancy - An Open-label Randomised Controlled Trial

JIPMER INTRAMURAL1 个研究点 分布在 1 个国家目标入组 266 人开始时间: 2021年7月20日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
266
试验地点
1
主要终点
To determine and compare the change in Bishop score with oral Mifepristone versus trans-cervical Foley catheter in women with singleton term and late term pregnancy undergoing pre-induction cervical ripening

研究概览

简要总结

Induction of labour is the most common obstetric procedure performed worldwide with an incidence of 25%.Success of labour induction depends on cervical “ripeness†or “favorabilityâ€.

Various pharmacological and mechanical methods are available for cervical ripening and induction of labor. Prostaglandin analogues like Dinoprostone(PGE2) and Misoprostol (PGE1) in various formulations are found to be more effective than Oxytocin,but are associated with the risk of uterine hyperstimulation, fetal distress and uterine rupture. Mechanical methods such asFoleycatheter and hygroscopic dilators are associated with decreased risk of uterine hyperstimulation but increased maternal and neonatal infectious morbidity.

Progesterone antagonist like Mifepristone has been extensively used for termination of pregnancy in 1st and 2nd trimester and term intrauterine fetal demise. It binds to progesterone receptor and blocks the action of progesterone at the cellular level thereby decreasing the myometrial quiescence state and increasing its sensitivity to uterotonic agents.

Several studies have shown that Mifepristone is a safe and effective way to ripen the cervix thereby inducing the labour process in term pregnancies with no adverse maternal or fetal events.There are no studies comparing the efficacy of Mifepristone with trans-cervical Foley catheter for pre-induction cervical ripening in term and late term pregnancy.

If this study results show better or comparable effect of Mifepristone as pre-induction ripening agent to Foley catheter, then it can be used in outpatient basis for cervical ripeningthereby decreasing hospital stay with less infectious morbidity.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Age ≥ 18 years
  • Period of gestation: 39 to 42 weeks
  • Singleton live fetus with cephalic presentation with reactive Non-stress Test
  • Bishop’s score ≤6
  • Intact membranes
  • Planned for induction of labour
  • Unscarred uterus.

排除标准

  • 1.Absolute contraindications for vaginal delivery 2.Patient requiring imminent delivery
  • Evidence of chorioamnionitis 4.Patients with known contraindications to Mifepristone.

结局指标

主要结局

To determine and compare the change in Bishop score with oral Mifepristone versus trans-cervical Foley catheter in women with singleton term and late term pregnancy undergoing pre-induction cervical ripening

时间窗: Bishop score will be reassessed at 24 hours and 48 hours after administration of Tablet Mifepristone

次要结局

  • To determine and compare the efficacy and safety of oral Mifepristone with trans-cervical Foley catheter in women with singleton term and late term pregnancy undergoing pre-induction cervical ripening

研究者

发起方
JIPMER INTRAMURAL
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验